Mettler-Toledo International Inc.

NYSE:MTD

Medical - Diagnostics & Research

Healthcare
$1,737.26 +1.47%

+$16.60 today

Market cap
$34.55B
Beta
1.26
P/E (TTM)
26.6
EPS (TTM)
$43.14
52W Low $1,023.05High $1,525.17

Volume 0.16M

Average 0.19M

MTD Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Mettler-Toledo International Inc.NYSE: MTD

Research & Development · Q2 FY2026 · quarter ended Jun 2026

Research & development grows in line with its trailing trend

Q2 FY2026 research & development of $52.99M rose 7.5% year over year, in line with the +7.9% change in trailing-twelve-month research & development. Sequentially, it rose 3.3% from the prior quarter. Over 3 fiscal years it compounded at +4.0% a year.

Context

  • Research & development amounted to 5.0% of revenue in FY2025, unchanged from a year earlier.
  • Research & development increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +7.5% toward the trailing-twelve-month pace of +7.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$52.99M+3.3% QoQ
Last fiscal yearDec 2025
$199.37M+5.3% YoY
LTMJun 2026
$208.01M+7.9% YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+7.5%——
1 year+5.3%——
3-year CAGR+4.0%——
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
199.37M USD
Year-over-year change
+5.3%
4-year CAGR
+4.1%

Research & Development vs competitors

How MTD compares with its peers on the latest reported figures

  • MTD's LTM Jun 2026 research & development of $208.01M is the 8th highest of the 10 companies compared; the peer median is $330.6M.
  • Its year-over-year change of +7.9% is the 4th highest of 9, against a peer median of +4.7%.
  • Research & development amounts to 5.0% of revenue for MTD, versus a peer median of 6.6%.
MTD Competitors Peer median
Research & Development for MTD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DHRDanaher CorporationLTM Sep 2026$1.67B +4.2%+1.5%6.5%
TMOThermo Fisher Scientific Inc.LTM Sep 2026$1.41B -0.7%-1.7%3.0%
AAgilent Technologies, Inc.LTM Jul 2026$485M +8.5%-0.9%6.6%
BRKRBruker CorporationLTM Jun 2026$393.5M -1.6%+18.8%11.2%
TDYTeledyne Technologies IncorporatedLTM Sep 2026$330.6M +37.7%-3.4%5.1%
WATWaters CorporationLTM Jul 2026$321.75M +71.7%+3.5%6.9%
RVTYRevvity, Inc.LTM Jul 2026$215.83M +5.2%-0.9%7.4%
MTDMettler-Toledo International Inc.LTM Jun 2026$208.01M +7.9%+4.0%5.0%
NOVTNovanta Inc.LTM Oct 2026$96.43M -1.5%+3.6%8.9%
IEXIDEX CorporationLTM Jun 2026$0 ——0.0%
Peer median (excluding MTD) $330.6M+4.7%+0.3%6.6%

Competitors are the stored peer set for MTD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue3.72B3.92B3.79B3.87B4.03B
Cost of Revenue1.61B1.68B1.62B1.62B1.64B
Gross Profit2.11B2.24B2.17B2.25B2.39B
Gross Margin56.7%57.2%57.3%58.2%59.4%
Research & Development169.77M177.12M185.28M189.36M199.37M
Selling, General & Admin943.98M938.46M904.11M936.3M998.31M
Operating Expenses1.11B1.12B1.09B1.13B1.27B
Depreciation & Amortization108.06M113.02M121.16M123.22M125.61M
EBITDA1.1B1.24B1.2B1.25B1.24B
EBITDA Margin29.7%31.6%31.7%32.3%30.9%
Operating Income994.74M1.13B1.08B1.13B1.12B
Operating Margin26.8%28.7%28.5%29.1%27.8%
Interest Income00000
Interest Expense43.24M55.39M77.37M74.63M68.52M
Other Income / Expenses(45.38M)(55.63M)(105.96M)(89.83M)(69.58M)
Income Before Tax949.36M1.07B973.73M1.04B1.05B
Pre-Tax Margin25.5%27.3%25.7%26.8%26.1%
Income Tax Expense180.38M198.09M184.95M174.08M179.72M
Net Income768.99M872.5M788.78M863.14M869.19M
Net Margin20.7%22.3%20.8%22.3%21.6%
EPS (Basic)33.2538.7936.1040.6742.17
EPS (Diluted)32.7838.4135.9040.4842.05
Weighted Avg Shares23.13M22.49M21.85M21.22M20.61M
Weighted Avg Shares (Diluted)23.46M22.72M21.97M21.32M20.67M

Mettler-Toledo International Inc.

NYSE:MTD

Intrinsic Alpha fair value

Locked

Current Price

$1,737.26

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.